Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Bono, J de"'
Autor:
Fizazi, K., Herrmann, K., Krause, B.J., Rahbar, K., Chi, K.N., Morris, M.J., Sartor, O., Tagawa, S.T., Kendi, A.T., Vogelzang, N., Calais, J., Nagarajah, J., Wei, X.X., Koshkin, V.S., Beauregard, J.M., Chang, B., Ghouse, R., DeSilvio, M., Messmann, R.A., Bono, J. de
Publikováno v:
Lancet Oncology, 24, 6, pp. 597-610
Lancet Oncology, 24, 597-610
Lancet Oncology, 24, 597-610
Item does not contain fulltext BACKGROUND: In VISION, the prostate-specific membrane antigen (PSMA)-targeted radioligand therapy lutetium-177 [(177)Lu]Lu-PSMA-617 (vipivotide tetraxetan) improved radiographic progression-free survival and overall sur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d9dd8451c8531167b2dd3539228bd92
https://doi.org/10.1016/s1470-2045(23)00158-4
https://doi.org/10.1016/s1470-2045(23)00158-4
Autor:
McVeigh, T.P., Sundar, R., Diamantis, N., Kaye, S.B., Banerji, U., Lopez, J.S., Bono, J. de, Graaf, W.T.A. van der, George, A.J.
Publikováno v:
European Journal of Cancer, 95, 20-29
European Journal of Cancer, 95, pp. 20-29
European Journal of Cancer, 95, pp. 20-29
Item does not contain fulltext INTRODUCTION: Adolescents and young adults (AYAs) diagnosed with cancer between ages 15-39 years may harbour germline variants associated with cancer predisposition. Such variants represent putative therapeutic targets,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::34d0ad2135827ae493b0dffbd9d961ce
http://hdl.handle.net/2066/196559
http://hdl.handle.net/2066/196559
Autor:
Basu, B., Ang, J., Blanco, M., Dowsett, M., Spicer, J., Tutt, A., Johnston, S., Wan, S., Bono, J. De, Swanton, C.
Publikováno v:
In EJC Supplements 2010 8(7):204-205
Autor:
Twelves, C J, Gardner, C, Flavin, A, Sludden, J, Dennis, I, Bono, J de, Beale, P, Vasey, P, Hutchison, C, Macham, M A, Rodriguez, A, Judson, I, Bleehen, N M
Publikováno v:
British Journal of Cancer; 8/1/99, Vol. 80 Issue 11, p1786, 6p
Autor:
Blagden, S., Bono, J. de
Publikováno v:
Current Drug Targets; May 2005, Vol. 6 Issue: 3 p325-335, 11p
Publikováno v:
Heart; 2018, Vol. 104 Issue: Supplement 2 pA1-A2, 2p
Autor:
Hollebecque, A1 (AUTHOR), Bono, J de2 (AUTHOR), Plummer, R3 (AUTHOR), Isambert, N4 (AUTHOR), Martin-Romano, P1 (AUTHOR), Baudin, E1 (AUTHOR), Mora, S5 (AUTHOR), Harding, A6 (AUTHOR), Nguyen, A7 (AUTHOR), Filvaroff, E7 (AUTHOR)
Publikováno v:
Annals of Oncology. 2018 Supplement, Vol. 29, pN.PAG-N.PAG. 1p.
Autor:
Sandhu, S K1 (AUTHOR), Hussain, M2 (AUTHOR), Mateo, J3 (AUTHOR), Fizazi, K4 (AUTHOR), Saad, F5 (AUTHOR), Shore, N6 (AUTHOR), Chi, K7 (AUTHOR), Sartor, O8 (AUTHOR), Agarwal, N9 (AUTHOR), Olmos, D10 (AUTHOR), Thiery-Vuillemin, A11 (AUTHOR), Twardowski, P12 (AUTHOR), Mehra, N13 (AUTHOR), Goessl, C14 (AUTHOR), Kang, J14 (AUTHOR), Burgents, J15 (AUTHOR), Wu, W14 (AUTHOR), Kohlmann, A16 (AUTHOR), Adelman, C16 (AUTHOR), Bono, J de17 (AUTHOR)
Publikováno v:
Annals of Oncology. 2019 Supplement, Vol. 30, pN.PAG-N.PAG. 1p.
Autor:
William Oh, Yixuan Gong, Matthias Heck, Matthew D. Galsky, Roman Nawroth, Eric E. Schadt, Johann S. de Bono, Uma Chippada-Venkata, Li Wang, Margitta Retz, Che-Kai Tsao, David Olmos, Jun Zhu
Publikováno v:
Repisalud
Instituto de Salud Carlos III (ISCIII)
BMC Medicine
Instituto de Salud Carlos III (ISCIII)
BMC Medicine
Castration-resistant prostate cancer (CRPC) is associated with wide variations in survival. Recent studies of whole blood mRNA expression-based biomarkers strongly predicted survival but the genes used in these biomarker models were non-overlapping a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20bece3b92e99eda2d9a7400a20bd626
https://hdl.handle.net/20.500.12105/10315
https://hdl.handle.net/20.500.12105/10315